SRShu Rong

Shu Rong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shu Rong has a total of 40 co-authors. Here are the top co-authors by number of shared publications:

  • Ling Wang

    Division of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    2 shared publications
  • Minghua Shang

    Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    2 shared publications
  • Weijie Yuan

    Department of Nephrology, Shanghai First People's Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China

    2 shared publications
  • Baozhen Zhao

    Department of Ultrasonography, Changhai Hospital, affiliated with the Second Military Medical University, Shanghai, China

    1 shared publication
  • Changlin Mei

    Kidney Institution of the Chinese People’s Liberation Army, Chang Zheng Hospital, The Navy Military Medical University, Shanghai, China

    1 shared publication
  • Chao Su

    Department of Nephrology, Hefei Maternity and Child Health Care Hospital, Hefei, China

    1 shared publication

Latest Publications

  • Open Access

    Autosomal dominant focal segmental glomerulosclerosis by INF2 p.Arg218Trp and p.Ser186Pro mutations: three case reports and literature review

    by Shunian Guo, Minghua Shang, Chao Su, Yifeng Zhuge, Wenqian Wei, Shu Rong, Lijie Gu

    Focal segmental glomerulosclerosis(FSGS) is a histologic lesion of podocyte injury with diverse etiologies including mutations in the inverted formin-2 gene(INF2), which belongs to the formin family and regulates actin cytoskeleton-dependent cellular processes. We report two cases of INF2 p.Arg218Trp and one case of p.Ser186Pro, all exhibiting an autosomal dominant(AD) inheritance pattern. The clinical presentations of the two patients with INF2 p.Arg218Trp varied widely. One patient, diagnosed with proteinuria in adolescence, maintained normal renal function, while the other experienced a youthful onset followed by rapid progression to end-stage renal disease (ESRD) and required hemodialysis treatment. The patient with p.Ser186Pro also had an early onset, with renal biopsy revealing progression from minimal change disease (MCD) to FSGS, leading to ESRD and necessitating hemodialysis treatment. These cases add to the clinical spectrum associated with INF2-related FSGS and underscore the importance of genetic evaluation in patients with early-onset or familial kidney disease. They show considerable intrafamilial and interfamilial variability in penetrance and expressivity, highlighting the complexity of genotype-phenotype correlations. Genetic screening and family counseling remain essential in suspected hereditary FSGS. Further studies are warranted to clarify the molecular mechanisms and guide management strategies.

  • Open Access

    Low protein diet supplemented with ketoacids on muscle wasting in chronic kidney disease: A clinical trial

    by Yueyue Zhang, Lijie Gu, Ling Wang, Shu Rong, Weijie Yuan

    Aim: Nutrition is an important part of the care of patients with chronic kidney disease (CKD). However, there is limited clinical research on the skeletal muscle nutrition of patients with CKD. We carried out this study to find out whether a low-protein diet supplemented with ketoacids (LPD + KA) could improve muscle wasting in patients with CKD.Methods: Patients were enrolled in this non-blind, parallel-group, randomized trial assessing the nutritional status of CKD, randomly assigned to either the LPD + KA group or conventional LPD group. Blood samples such as Hemoglobin, Cystatin C, Creatinine, BUN, Albumin, Pre- Albumin, Glycerin Trilaurate, and Cholesterol were measured at baseline and every 3 months. The parameters of skeletal muscle and other body composition were assessed before and after dietary intervention for 12 months.Results: A total of 58 patients with CKD completed the study and were available for further analysis. The hemoglobin and albumin were observed to be markedly improved in the LPD + KA group during the follow-up as compared to baseline. Body mass index and total body water index of both groups were increased upon follow-up but the increase in the LPD + KA group was comparatively higher. Moreover, an increase in body fat%, skeletal muscle mass index, and appendicular skeletal muscle mass index was observed in both groups between baseline and follow-up, but it was statistically insignificant.Conclusion: This study did not find a significant improvement of KAs on muscle wasting, and a long time or more indices study may need to find the effects of the LPD + KA diets.Clinical trial registration: [www.ClinicalTrials.gov], identifier [NCT02568020].


  • Open Access

    Calpain 6 inhibits autophagy in inflammatory environments: A preliminary study on myoblasts and a chronic kidney disease rat model

    by Yue Yue Zhang, Li Jie Gu, Nan Zhu, Ling Wang, Min Chao Cai, Jie Shuang Jia, Shu Rong, Wei Jie Yuan

    A non‑classical calpain, calpain 6 (CAPN6), can inhibit skeletal muscle differentiation and regeneration. In the present study, the role of CAPN6 in the regulation of the autophagy of myoblasts in vitro was investigated. The underlying molecular events and the CAPN6 level in atrophic skeletal muscle in a rat model of chronic kidney disease (CKD) were also investigated. In vitro, CAPN6 was overexpressed, or knocked down, in rat L6 myoblasts to assess autophagy and related gene expression and co‑localization. Subsequently, myoblasts were treated with a mixture of cytokines, and relative gene expression and autophagy were assessed. A rat model of CKD for muscle atrophy was established, and blood chemical level and the expression of CAPN6 in muscle were assessed. The data revealed that the knockdown of CAPN6 in rat myoblasts resulted in increased microtubule‑associated protein 1 light chain 3 (LC3) levels, while its overexpression decreased LC3 levels and impaired autophagy. Additionally, it was observed that the co‑localization of mammalian target of rapamycin (mTOR) and lysosomal‑associated membrane protein 1 (LAMP1), a lysosomal marker, proteins was increased. In addition, mTOR, Raptor and α‑tubulin (a marker of microtubules) increased in the CAPN6 overexpression group. However, inflammatory cytokines, such as interleukin (IL)‑6, tumor necrosis factor (TNF)‑α, interferon (INF)‑γ and lipopolysaccharides upregulated CAPN6 expression, inhibited L6 myoblast autophagy and stabilized mTOR activity. Furthermore, the animal model successfully mimicked human disease as regards an increase in body weight, and a reduction in muscle mass, cross‑sectional area and blood biomarker concentrations; a slight increase in CAPN6 mRNA and protein levels in muscles was observed. Finally, the data of the present study suggested that CAPN6 reduced autophagy via the maintenance of mTOR signaling, which may play a role in CKD‑related muscle atrophy. However, future studies are required to determine whether CAPN6 may be used as an intervention target for CKD‑related skeletal muscle atrophy.


  • Effect of Sheng Xue Ning Tablets on Renal Anemia in Patients Subject to Maintenance Hemodialysis and Safety Evaluation: A Multi-setting Prospective Randomized Study

    by Xiao-Jing Tang, Shu Rong, Chang-Lin Mei, Zhao-Hui Ni, Geng-Ru Jiang, Wei-Jie Yuan, Nian-Song Wang, Zhi-Yong Guo, Jun Ma, Hai-Dong Yan, et al.

    This study compared Sheng Xue Ning (SXN) tablets with ferrous succinate (FS) tablets in terms of their efficacy for the treatment of iron-deficient renal anemia and safety in patients subject to maintenance hemodialysis (MHD). A total of 94 patients undergoing MHD were randomly assigned to an experiment group (receiving oral SXN tablets, SXN group) and a control group (orally given FS tablets, FS group) and followed up for 12 weeks. Erythropoietin (EPO) was used in both groups. The efficacy was assessed by detecting the subsequent changes in hemoglobin (Hb), serum iron (SI), SF and transferrin saturation (TSAT). At the 12th week, Hb and TSAT levels in both groups were significantly increased compared to those in the screening period (P<0.05). However, no significant difference in Hb and TSAT was found between the two groups. The average weekly EPO dosage used was lower in SXN group than in FS group (P<0.05) at the 10th week and the 12th week. Our study showed that SXN tablets can effectively ameliorate renal anemia and keep iron metabolism stable in MHD patients, and its efficacy is virtually close to that of FS tablets. Meanwhile, SXN tablets can reduce the dosage of EPO and have a good safety profile.


  • Open Access

    Risk factors for heart valve calcification in chronic kidney disease

    by Shu Rong, Xin Qiu, Xiucai Jin, Minghua Shang, Yixin Huang, Zhihuan Tang, Weijie Yuan

    Cardiovascular disease (CVD) is a common cause of death in patients with chronic kidney disease (CKD). Aortic and mitral valve calcification (AVC and MVC, respectively) are critical indicators of CVD and all-cause mortality in CKD patients. We conducted a single center retrospective study of Chinese inpatients with CKD to identify risk factors associated with valve calcification (VC). Of 288 enrolled CKD patients, 22.9% had VC, all of which exhibited AVC, while 21.2% exhibited MVC. The VC group were significantly older than the non-VC group (70.42 ± 11.83 vs 56.47 ± 15.00, P < .001), and contained more patients with history of coronary artery disease (12.1% vs 4.5%, P = .025) or stroke (18.2% vs 5.4%, P < .001). Subjective global assessment scoring indicated that more VC patients were mid/severely malnourished. Levels of prealbumin, cholesterol (Ch), triglycerides, low-density lipoprotein (LDL), apolipoprotein E, ejection fraction, and fraction shortening were significantly lower, and blood C reactive protein, IL-6, left ventricular internal end diastole diameter measured in end diastole, and interventricular septum thickness (IVST) levels were significantly higher in the VC group. Bone metabolism did not differ significantly between the 2 groups. Multivariable logistic regression analysis indicated that age, blood Ch, and LDL levels were significantly associated with VC. Advanced age, increased IVST, hypocholesterolemia, and hyper-LDL cholesterolemia were key risk factors for VC in Han patients with CKD.


  • Preliminary Evaluation of Virtual Touch Tissue Imaging Quantification for Differential Diagnosis of Metastatic and Nonmetastatic Cervical Lymph Nodes

    by Yingyan Zhao, Jiaying Xi, Baozhen Zhao, Wenfeng Xiong, Dong Jiang, Li Yang, Zhuhong Cai, Tianjia Liu, Haibo Jiang, Shu Rong, et al.

    Objectives: Virtual Touch tissue imaging quantification (VTIQ; Siemens Medical Solutions, Mountain View, CA) is useful for assessing tissue hardness. This study aimed to investigate the value of VTIQ in differential diagnosis of cervical lymph nodes.Methods: We retrospectively analyzed conventional sonograms and VTIQ images of 85 pathologically confirmed patients with superficial lymph node lesions. Conventional sonography was first performed, with 2‐dimensional images described. Then VTIQ shear wave velocity (SWV) values of superficial lymph nodes were measured. With pathologic diagnosis as the reference standard, a receiver operating characteristic curve was generated to evaluate VTIQ efficacy in differential diagnosis of metastatic and nonmetastatic cervical lymph nodes.Results: Of the 85 nodes, 44 and 41 were metastatic and nonmetastatic, respectively. The latter group included 24 and 17 hematologic/lymphatic system disease and reactive hyperplastic nodes, respectively. Shear wave velocity values of metastatic nodes were significantly higher than those of their nonmetastatic counterparts (P < .001). With an area under the curve (AUC) of 0.953 and SWV cutoff of 3.27 m/s, accuracy, sensitivity, and specificity were 89.4%, 88.6%, and 90.2%, respectively, for distinguishing metastatic and nonmetastatic nodes. An AUC of 0.943 and SWV cutoff of 3.23 m/s yielded accuracy, sensitivity, and specificity of 88.2%, 88.6%, and 87.5% for differentiating metastatic from hematologic/lymphatic system disease nodes. Finally, an AUC of 0.968 and SWV cutoff of 3.27 m/s yielded accuracy, sensitivity, and specificity of 90.2%, 88.6%, and 94.1% for differentiating metastatic from reactive hyperplastic nodes.Conclusions: Virtual Touch tissue imaging quantification is efficient in differential diagnosis of metastatic and nonmetastatic cervical lymph nodes.